News

Join Medable, GSK, and Lightship's Sepehr Shojaei for a panel discussion on how a trial platform as a service can enhance, expedite, and improve the day-to-day operations of clinical operations across the life cycle of a study.  

Join Define Ventures' life sciences forum, Patient Centricity Meets Clinical Research: Next Gen Models in Pharma Innovation and David MacMurchy, CEO of Lightship on Sept. 12th at 9am PT. During this panel, we will be unpacking how technology and consumer-first thinking can be implemented by sponsors, CROs, and startups to drive value for patients and the broader pharma ecosystem.

Lightship co-founder Samantha Eells was featured in the Women In Pharma supplement of International Clinical Trials (Samedan Ltd). Click through for a thoughtful discussion about the impact of decentralization on clinical trial diversity.

Clinical trials play a pivotal role in advancing medicine and public health. However, traditional clinical trials often fail to provide adequate access and representation for diverse populations. In the latest episode of the HealthBiz Podcast, Samantha Eells — co-founder of Lightship — discussed her journey to revolutionizing clinical trials and improving the patient experience. Lightship aims to make clinical trials more accessible and patient-centric, with a focus on addressing health disparities.

Listen to Samantha Eells- Co-founder of Lightship, share her thoughts on tailoring recruitment strategies to meet patients' needs for successful trials in The Spark's latest podcast episode.

Lightship Inc. announces meeting with FDA’s Digital Health Technologies Steering Committee to review approaches to create more access and choice for oncology patients taking part in clinical research.

The nonprofit Digital Medicine Society and industry collaborators, including Lightship, have launched anew resource platform designed to advance diversity, equity and inclusion (DEI) in digitized clinical trials.

For Lightship, increasing patient access to clinical trials is about meeting them where they are — literally.

Meeting people where they are to increase access to clinical trials.

Sepehr Shojaei and Rachael Scott discuss the use of hybrid clinical trial solutions across therapy areas.

Building trust in clinical trials and creating non-biased data sets. Acclinate and Lightship discuss the importance of inclusion in clinical research.

Rachael Scott reviews the challenges and potential solutions for more inclusive clinical trials.

Micky is a Distinguished Professor at Duke University joining Lightship as Chief Medical Advisor.